Metabolomics in neonatology: Fact or fiction?

Seminars in Fetal and Neonatal Medicine

Volumn 18, Issue 1, 2013, Pages 3-12

  Fanos, V ^a   Van den Anker, J ^b   Noto, A ^a   Mussap, M ^c   Atzori, L ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Biomarkers; Metabolomics; Newborn; Perinatology; Physiopathology; Urine

Indexed keywords

3 HYDROXYBUTYRIC ACID; 3 HYDROXYKYNURENINE; 3 NITROTYROSINE; ACETOACETIC ACID; ACETYLCYSTEINE; ALANINE; CITRIC ACID; CREATINE; DECANOIC ACID; DIMETHYLGLYCINE; GALACTITOL; GENTAMICIN; GLUTARIC ACID; KYNURENINE; LAURIC ACID; LIGNOCERIC ACID; MALONALDEHYDE; METHYLGUANIDINE; MYRISTIC ACID; N ACETYLGLUTAMIC ACID; N ACETYLTYROSINE; N(G),N(G) DIMETHYLARGININE; PALMITIC ACID; PHOSPHATE; PHOSPHOETHANOLAMINE; PROLINE; PUTRESCINE; SPHINGOMYELIN; STEARIC ACID; UNINDEXED DRUG;

ACUTE KIDNEY FAILURE; ANTIBIOTIC THERAPY; ARTIFICIAL MILK; BIOMICS; BODY FLUID; BRAIN INJURY; BREAST MILK; CESAREAN SECTION; DERIVATIZATION; DIABETES MELLITUS; EPIGENETICS; EXTREMELY LOW BIRTH WEIGHT; GENOTYPE; GESTATIONAL AGE; HEART ARRHYTHMIA; HEART VENTRICLE HYPERTROPHY; HUMAN; INFLAMMATION; INTRAUTERINE GROWTH RETARDATION; KIDNEY DYSPLASIA; LUNG LAVAGE; MASS SPECTROMETRY; METABOLIC DISORDER; METABOLOMICS; NECROTIZING ENTEROCOLITIS; NEONATOLOGY; NEWBORN MORTALITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; NUTRITIONAL STATUS; OXIDATIVE STRESS; PERINATAL ASPHYXIA; PERINATAL PERIOD; PHARMACOMETABOLOMICS; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; PROTON NUCLEAR MAGNETIC RESONANCE; RESPIRATORY DISTRESS SYNDROME; REVIEW; SALIVA ANALYSIS; SENSITIVITY AND SPECIFICITY; SEPSIS; TIME OF FLIGHT MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; URINARY TRACT INFECTION; VAGINAL DELIVERY; VESICOURETERAL REFLUX;

GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; METABOLOMICS; NEONATOLOGY;

EID: 84871935674     PISSN: 1744165X     EISSN: 18780946     Source Type: Journal    
DOI: 10.1016/j.siny.2012.10.014     Document Type: Review

References (82)

1. Fanos V., Barberini L., Antonucci R., et al. Metabolomics in neonatology and pediatrics. Clin Biochem 2011, 44:452-454.
2. Fanos V., Yurdakök M. Personalized neonatal medicine. J Matern Fetal Neonatal Med 2010, 23:4-6.
3. Nicholson J.K., Lindon J.C. Systems biology: metabonomics. Nature 2008, 455:1054-1056.
4. Oliver S.G., Winson M.K., Kell D.B., Baganz F. Systematic functional analysis of the yeast genome. Trends Biotechnol 1998, 16:373-378.
5. Nicholson J.K., Lindon J.C., Holmes E. 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica 1999, 29:1181-1189.
6. Baker M. Metabolomics: from small molecules to big ideas. Nat Methods 2011, 2:219-221.
7. Christians U. The role of metabolomics in the study of kidney diseases and in the development of diagnostic tools. Biomarkers of kidney disease 2011, Elsevier, London. C.L. Edelstein (Ed.).
8. Griffin J.L. The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball?. Phil Trans R Soc Lond B Biol Sci 2006, 361:147-161.
9. Ellis D.I., Dunn W.B., Griffin J.L., Allwood J.W., Goodacre R. Metabolic fingerprinting as a diagnostic tool. Pharmacogenomics 2007, 8:1243-1266.
10. Barberini L., Antonucci R., et al. Pharma-metabolomics in neonatology: is it a dream or a fact?. Curr Pharmaceut Des. 2012, 18:2996-3006.
11. Oliver S.G. Functional genomics: lessons from yeast. Phil Trans R Soc Lond B Biol Sci 2002, 357:17-23.
12. Fanos V. Pediatric and neonatal individualized medicine. J Pediatr Neonaty Individual Med 2012, 1(1):7-10.
13. Nilsen M. Reinventing discovery: the new era of networked science 2011, Princeton University Press, Princeton, NJ.
14. Tordera M.P. Complexity in asthma: inflammation and scale-free networks. Arch Bronconeumol 2009, 45:459-465.
15. Gomase V.S., Changbhale S.S., Patil S.A., Kale K.V. Metabolomics. Curr Drug Metab 2008, 9:89-98.
16. Coen M., Holmes E., Lindon J.C., Nicholson J.K. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. Chem Res Toxicol 2008, 21:9-27.
17. Antonucci R., Atzori L., Barberini L., Fanos V., et al. Metabolomics: the " new clinical chemistry" for personalized neonatal medicine. Minerva Pediatr 2010, 62(3 Suppl. 1):145-148.
18. Atzori L., Antonucci R., Barberini L., Griffin J.L., Fanos V. Metabolomics: a new tool for the neonatologist. J Matern Fetal Neonatal Med 2009, 22(Suppl. 3):50-53.
19. Goodpaster A.M., Ramadas E.H., Kennedy M.A. Potential effect of diaper and cotton ball contamination on NMR- and LC/MS-based metabonomics studies of urine from newborn babies. Analyt Chem 2011, 83:896-902.
20. Fanos V., Antonucci R., Barberini L., Aztori L. Urinary metabolomics in the newborn and infants. Adv Clin Chem 2012, 58:193-223.
21. Castagnola M., Cabras T., Iavarone F., et al. Top-down platform for deciphering the human salivary proteome. J Matern Fetal Neonat Med 2012, 25(Suppl. 5):27-43.
22. Dunn W.B., Broadhurst D.I., Atherton H.J., et al. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev 2011, 40:387-426.
23. Tworoger S.S., Hankinson S.E. Collection, processing, and storage of biological samples in epidemiologic studies: sex hormones, carotenoids, inflammatory markers, and proteomics as examples. Cancer epidemiology, biomarkers and prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Cancer Epidemiol Biomarkers Prev 2006, 15:1578-1581.
24. Koster S., Verpoorte E. A decade of microfluidic analysis coupled with electrospray mass spectrometry: an overview. Lab Chip 2007, 7:1394-1412.
25. Griffin J.L., Atherton H., Shockcor J., Atzori L. Metabolomics as a tool for cardiac research. Nat Rev Cardiol 2011, 8:630-643.
26. Wishart D.S. Metabolomic: application to food science and nutrition research. Trends Food Sci Technol 2008, 19:482-493.
27. Kristal B.S., Shurubor Y.I., Kaddurah-Daouk R., Matson W.R. High-performance liquid chromatography separations coupled with coulometric electrode array detectors: a unique approach to metabolomics. Methods Mol Biol 2007, 358:159-174.
28. Lindon J.C., Keun H.C., Ebbels T.M., et al. The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements. Pharmacogenomics 2005, 6:691-699.
29. Groombridge C.J. NMR spectroscopy in forensic science. Annu Rep NMR Spectrosc 1996, 32:215.
30. Lindon J.C., Nicholson J.K., Holmes E., et al. Metabonomics: metabolic processes studied by NMR spectroscopy of biofluids. Concepts Magn Reson 2000, 12:289-320.
31. Dettmer K., Aronov P.A., Hammock B.D. Mass spectrometry-based metabolomics. Mass Spectrom Rev 2007, 26:51-78.
32. Forshed J., Torgrip R.J.O., Aberg K.M., et al. A comparison of methods for alignment of NMR peaks in the context of cluster analysis. J Pharmaceut Biomed Anal 2005, 38:824-832.
33. Lindon J.C., Nicholson J.K. Spectroscopic and statistical techniques for information recovery in metabonomics and metabolomics. Annu Rev Anal Chem 2008, 1:45-69.
34. Westerhuis J.A., Hoefsloot H.C.J., Smit S., et al. Assessment of PLSDA cross validation. Metabolomics 2008, 4:81-89.
35. Kouskoumvekaki I., Panagiotou G. Navigating the human metabolome for biomarker identification and design of pharmaceutical molecules. J Biomed Biotechnol 2011, 2011:525497.
36. Syggelou A., Iacovidou N., Atzori L., Xanthos T., Fanos V. Metabolomics in the developing human being. Pediatr Clin North Am 2012, 59:1039-1058.
37. 1H NMR-based metabolomic analysis of urine from term and preterm neonates. J Neonatal Perinatal Med 2009, 2:216. [abstract].
38. 1H NMR-based metabolomic analysis of urine from preterm and term neonates. Front Biosci (Elite Ed) 2011, 3:1005-1012.
39. Ciccarelli S., Atzori L., Noto A., et al. Spontaneous vs cesarean delivery: a metabolomic point of view. J Matern Fetal Neonatal Med 2011, 24:I-II. [abstract].
40. Hyde M.J., Griffin J.L., Herrera E., et al. Delivery by Caesarean section, rather than vaginal delivery, promotes hepatic steatosis in piglets. Clin Sci 2010, 118:47-59.
41. Fanos V. Perinatal metabolomics (Lecture). 14th International Congress on Twins Pregnancy, Florence, 1-4 April 2012. Twin Res Hum Genet 2012, 15:193.
42. Noto A., Paladini L., Paladini A., et al. Metabolomics in twins at birth. Proceedings of the XX European Workshop on Neonatology, Tallin, June 2012. Abstract 12. J Perinat Med 2012, 2:195.
43. Solberg R., Enot D., Deigner H.P., et al. Metabolomic analyses of plasma reveals new insights into asphyxia and resuscitation in pigs. PLoS One 2010, 5:e9606.
44. Beckstrom A.C., Humston E.M., Snyder L.R., et al. Application of comprehensive two-dimensional gas chromatography with time-of-flight mass spectrometry method to identify potential biomarkers of perinatal asphyxia in a non-human primate model. J Chromatogr A 2011, 1218:1899-1906.
45. Atzori L., Xanthos T., Barberini L., et al. A metabolomic approach in an experimental model of hypoxia-reoxygenation in newborn piglets: urine predicts outcome. J Matern Fetal Neonatal Med 2010, 23(Suppl. 3):134-137.
46. 31P NMR after mild hypothermia treatments of oxygen-glucose deprivation in a neonatal brain slice model of asphyxia. J Cereb Blood Flow Metab 2011, 31:547-559.
47. Fanos V., Atzori L., Dessì A., D'Aloja E., Finco G., Faa G. The kidney in post-asphyctic syndrome: state of the art. Developmental nephrology: from embryology to metabolomics 2011, Hygeia Press, Quartu Sant'Elena. V. Fanos, R.L. Chevalier, G. Faa, L. Cataldi (Eds.).
48. Nissen P.M., Nebel C., Oksbjerg N., Bertram H.C. Metabolomics reveals relationship between plasma inositols and birth weight: possible markers for fetal programming of type 2 diabetes. J Biomed Biotechnol 2011, 2011. pii: 378268.
49. Alexandre-Gouabau M.C., Courant F., Le Gall G., et al. Offspring metabolomic response to maternal protein restriction in a rat model of intrauterine growth restriction (IUGR). J Proteome Res 2011, 10:3292-3302.
50. Dessì A., Atzori L., Noto A., et al. Metabolomics in newborns with intrauterine growth retardation (IUGR): urine reveals markers of metabolic syndrome. J Matern Fetal Neonatal Med 2011, 24(Suppl. 2):35-39.
51. Favretto D., Cosmi E., Ragazzi E., et al. Cord blood metabolomic profiling in intrauterine growth restriction. Analyt Bioanalyt Chem 2012, 402:1109-1121.
52. Ivorra C., García-Vicent C., Chaves F.J., et al. Metabolomic profiling in blood from umbilical cords of low birth weight newborns. J Transl Med 2012, 10:142.
53. 1H-NMR-based metabolic profiling of maternal and umbilical cord blood indicates altered materno-foetal nutrient exchange in preterm infants. PLoS One 2012, 7:e29947.
54. Horgan R.P., Broadhurst D.I., Dunn W.B., et al. Changes in the metabolic footprint of placental explant-conditioned medium cultured in different oxygen tensions from placentas of small for gestational age and normal pregnancies. Placenta 2010, 31:893-901.
55. Keller M., Enot D.P., Hodson M.P., et al. Inflammatory-induced hibernation in the fetus: priming of fetal sheep metabolism correlates with developmental brain injury. PLoS One 2011, 6:e29503.
56. Atzei A., Atzori L., Moretti C., et al. Metabolomics in paediatric respiratory diseases and bronchiolitis. J Matern Fetal Neonatal Med 2011, 24(Suppl. 2):59-62.
57. Mattarucchi E., Baraldi E., Guillou C. Metabolomics applied to urine samples in childhood asthma; differentiation between asthma phenotypes and identification of relevant metabolites. Biomed Chromatogr 2012, 26:89-94.
58. Fabiano A., Gazzolo D., Zimmermann L.J., et al. Metabolomic analysis of bronchoalveolar lavage fluid in preterm infants complicated by respiratory distress syndrome: preliminary results. J Matern Fetal Neonatal Med 2011, 24(Suppl. 2):55-58.
59. Bruder E.D., Raff H. Cardiac and plasma lipid profiles in response to acute hypoxia in neonatal and young adult rats. Lipids Health Dis 2010, 9:3.
60. 1H-NMR spectroscopy- and mass spectrometry-based metabolomic study of the PPAR-alpha null mutant mouse defines profound systemic changes in metabolism linked to the metabolic syndrome. Physiol Genomics 2006, 27:178-186.
61. Dunn W.B., Goodacre R., Neyses L., Mamas M. Integration of metabolomics in heart disease and diabetes research: current achievements and future outlook. Bioanalysis 2011, 3:2205-2222.
62. Mervaala E., Biala A., Merasto S., et al. Metabolomics in angiotensin II-induced cardiac hypertrophy. Hypertension 2010, 55:508-515.
63. 1H-NMR (nuclear magnetic resonance) spectroscopy of urine at birth predictive as ultrasound?. J Matern Fetal Neonatal Med 2011, 24(Suppl. 2):I. [abstract].
64. 1H NMR-based metabolic profiling of urine from children with nephrouropathies. Front Biosci (Elite Ed) 2010, 2:725-732.
65. Hanna M, Segar S, Teesch L, Brophy P. Metabolomics markers of nephrotoxicity in newborn rats. Poster presented at joint meeting of Pediatric Academic Societies/Asian Society for Pediatric Research, April-May 2011, Denver, CO, USA.
66. Lv H., Liu L., Song T., Lu J., et al. Ingenuity pathways analysis of urine metabonomics phenotypes toxicity of gentamicin in multiple organs. Mol Biosyst 2010, 6:2056-2067.
67. Beger R.D., Holland R.D., Sun J., et al. Metabonomics of acute kidney injury in children after cardiac surgery. Pediatr Nephrol 2008, 23:977-984.
68. Weiss R.H., Kim K. Metabolomics in the study of kidney diseases. Nat Rev Nephrol 2011, 8:22-33.
69. Wikoff W.R., Gangoiti J.A., Barshop B.A., Siuzdak G. Metabolomics identifies perturbations in human disorders of propionate metabolism. Clin Chem 2007, 53:2169-2176.
70. Izquierdo-García J.L., Nin N., Ruíz-Cabello J., et al. A metabolomic approach for diagnosis of experimental sepsis. Intensive Care Med 2011, 37:2023-2032.
71. Liu X.R., Zheng X.F., Ji S.Z., et al. Metabolomic analysis of thermally injured and/or septic rats. Burns 2010, 36:992-998.
72. Lacy P. Metabolomics of sepsis-induced acute lung injury: a new approach for biomarkers. Am J Physiol Lung Cell Mol Physiol 2011, 300:L1-L3.
73. Jiang P, Berri T, Ladegaard JM, et al. Urine metabolome of preterm neonates with treatment of antibiotics. Metabomeeting 2011, Helsinki, 25-28 September 2011, Poster 54.
74. Cesare Marincola F., Noto A., Caboni P., et al. A metabolomic study of preterm human and formula milk by high resolution NMR and GC/MS analysis: preliminary results. J Matern Fetal Neonat Med 2012, 25(Suppl. 5):62-67.
75. Atzori L., Griffin J.L., Noto A., et al. Metabolomics: a new approach to drug delivery in perinatology. Curr Med Chem 2012 Aug 9, [Epub ahead of print].
76. Antonucci R., Pilloni M.D., Atzori L., Fanos V. Pharmaceutical research and metabolomics in the newborn. J Matern Fetal Neonat Med 2012, 25(Suppl. 5):22-26.
77. Atzori L., Mussap M., Noto A., et al. Clinical metabolomics and urinary NGAL for the early prediction of chronic kidney disease in healthy adults born ELBW. J Matern Fetal Neonatal Med 2011, 24(Suppl. 2):40-43.
78. Modi N., Hyde M.J., Parkinson J., et al. Deciphering the metabolic pathways perturbed by preterm birth. J Neonatal Perinatal Med 2010, 3:254.
79. Broadhurst D.I., Kell D.B. Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics 2006, 2:171-196.
80. Cantor G.H. Metabolomics and mechanisms: sometimes the fisherman catches a big fish. Toxicol Sci 2010, 118:321-323.
81. Griffiths W.J., Koal T., Wang Y., Kohl M., Enot D.P., Deigner H.P. Targeted metabolomics for biomarker discovery. Angew Chem Int Ed Engl 2010, 49:5426-5445.
82. Livengood P., Maciejewski R., Chen W., Ebert D.S. OmicsVis: an interactive tool for visually analyzing metabolomics data. BMC Bioinform 2012, 13(Suppl. 8):S6.